Live Markets

Loading markets...

#Psilocybin

Psychedelic Therapy Side Effects: The FDA Fast-Track Crisis

Psychedelic Therapy Side Effects: The FDA Fast-Track Crisis

July 01, 2026

FDA Psychedelic Fast Track: 2026 Mandate Accelerates Therapies

FDA Psychedelic Fast Track: 2026 Mandate Accelerates Therapies

May 02, 2026

FDA Psychedelic Approval 2026: Fast-Tracking PTSD & Depression Cures

FDA Psychedelic Approval 2026: Fast-Tracking PTSD & Depression Cures

April 29, 2026

FDA Psychedelic Drug Approval Fast-Tracked for Depression and PTSD

FDA Psychedelic Drug Approval Fast-Tracked for Depression and PTSD

April 29, 2026

FDA Psychedelic Therapy 2026: Fast-Tracking PTSD & Depression

FDA Psychedelic Therapy 2026: Fast-Tracking PTSD & Depression

April 28, 2026

FDA Psychedelic Approval 2026: Fast-Tracking PTSD Breakthroughs

FDA Psychedelic Approval 2026: Fast-Tracking PTSD Breakthroughs

April 27, 2026

New Executive Order Fast-Tracks Psychedelic Therapy FDA Approval

New Executive Order Fast-Tracks Psychedelic Therapy FDA Approval

April 22, 2026

Breakthrough Psychedelic Therapy 2026 Study Reveals Brain Rewiring

Breakthrough Psychedelic Therapy 2026 Study Reveals Brain Rewiring

April 09, 2026

Psilocybin Therapy FDA Approval 2026: COMP360 Nears Submission

Psilocybin Therapy FDA Approval 2026: COMP360 Nears Submission

March 24, 2026

Latest COMP360 Phase 3 Results: Psilocybin for Depression

Latest COMP360 Phase 3 Results: Psilocybin for Depression

March 10, 2026